Empirical antimicrobial therapy of acute dentoalveolar abscess

Vojnosanitetski Pregled

Volumn 66, Issue 7, 2009, Pages 544-550

  Matijević, Stevo ^a   Lazić, Zoran ^a   Kuljić Kapulica, Nada ^b   Nonković, Zorka ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b Institute of Microbiology   (Serbia)

Author keywords

Amoxicillin; Cephalosporins; Microbiological techniques; Periapcial abscess; Tooth extraction

Indexed keywords

AMOKSICILIN; AMOXICILLIN; CEFALEKSIN; CEFALEXIN; UNCLASSIFIED DRUG;

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEVER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCISION; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SUPPURATION; SWELLING; SYMPTOM; TOOTH ABSCESS; TRISMUS;

EID: 68249093659     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP0907544M     Document Type: Article

References (37)

1. Marsh PD, Martin MV, Lewis MAO, Williams DW. Oral microbiology. 5th ed. Reed Educational and Professional Publishing; 2002.
2. Gutiérrez-Pérez JL, Perea-Pérez EJ, Romero-Ruiz MM, Girón-González JA. Orofacial infections of odontogenic origin. Med Oral 2004; 9(4): 280-287 (English, Spanish)
3. Peterson JL. Principles of management and prevention of odontogenic infections. In: Peterson JL, Ellis E, Hupp JR, Tucker MR, editors. Contemporary Oral and Maxillofacial Surgery. St. Louis: Mosby-year book; 1998. p. 392-512.
4. Peterson JL. Principles of management and antimicrobal infections management. In: Topazin R, Goldberg M, Hupp RJ, editors. Oral and Maxillofacial Infections. 4th ed. Philadelphia: W.B. Sounders Co; 2002. p. 99-112.
5. Leković V, Lekić P, Petrović V. Antibiotics of dentristry praxis. Belgrade: Naučna knjiga; 1992. p. 57-92. (Serbian)
6. th ed. St. Louis: Mosby-Year Book, 1998. p. 482-545.
7. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N Engl J Med 1994; 330(17): 1247-1251 (Pubitemid 24122005)
8. Bischof WH. The use of systemic antibiotics in dental practice. Ann R Australas Coll Dent Surg 1998; 14: 62-65
9. Prostran MS, Kažić T. Antibiotics - rational use. Belgrade: Srpsko lekarsko društvo; 1997. (Serbian)
10. Simić D, Kažić T. Antibacterial medications. In: Simić D, editor. Rational therapy. 6th extended ed. Belgrade: Naučna knjiga; 1993. p. 91-130. (Serbian)
11. Martindale. The extra pharmacopoeia. 31st ed. London: Royal Pharmaceutical Society; 1996. pp. 2739.
12. Hancock RE. Peptide antibiotics. Lancet 1997; 349(9049): 418-422
13. Goldberg HM, Topazin GR. Odontogenic infections and deep fascial space infections of dental. In: Topazin GR, Goldberg HM, Hupp RJ, editoros. Oral and maxillofaciall infections. 4th ed. Philadelphia: W.B. Sounders Co; 2002. p. 158-188
14. Al-Belasy FA, Hairam AR. The efficacy of azithromycin in the treatment of acute infraorbital space infection. J Oral Maxillofac Surg 2003; 61(3): 310-316
15. Martin MV, Longman LP, Hill JB, Hardy P. Acute dentoalveolar infections: an investigation of the duration of antibiotic therapy. Br Dent J 1997; 183(4): 135-137 (Pubitemid 127517814)
16. Fazakerley MW, McGowan P, Hardy P, Martin MV. A comparative study of cephradine, amoxycillin and phenoxymethylpenicillin in the treatment of acute dentoalveolar infection. Br Dent J 1993; 174(10): 359-363
17. Topazin GR, Goldberg HM, Hupp RJ, editoros. Oral and maxillofaciall infections. 4th ed. Philadelphia: W.B. Sounders Co; 2002.
18. Peterson JL. Principles of antibiotic therapy. In: Topazin R, Goldberg M, editors. Oral and Maxillofacial Infections. 2nd ed. Philadelphia: W.B. Sounders Co; 1987. p. 122-156
19. Lewis MA, McGowan DA, MacFarlane TW. Short-course high-dosage amoxycillin in the treatment of acute dento-alveolar abscess. Br Dent J 1986; 161(8): 299-302.
20. Sixou JL, Magaud C, Jolivet-Gougeon A, Cormier M, Bonnaure-Mallet M. Microbiology of mandibular third molar pericoronitis: incidence of beta-lactamase-producing bacteria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95(6):655-659 (Pubitemid 36886677)
21. Baumgartner JC, Xia T. Antibiotic susceptibility of bacteria associated with endodontic abscesses. J Endod 2003; 29(1): 44-47 (Pubitemid 41582841)
22. Rega AJ, Aziz SR, Ziccardi VB. Microbiology and antibiotic sensitivities of head and neck space infections of odontogenic origin. J Oral Maxillofac Surg 2006; 64(9): 1377-1380
23. Brescó-Salinas M, Costa-Riu N, Berini-Aytés L, Gay-Escoda C. Antibiotic susceptibility of the bacteria causing odontogenic infections. Med Oral Patol Oral Cir Bucal 2006; 11(1): E70-5. (English, Spanish)
24. Chan Y, Chan CH. Antibiotic resistance of pathogenic bacteria from odontogenic infections in Taiwan. J Microbiol Immunol Infect 2003; 36(2): 105-110 (Pubitemid 36850619)
25. Dirks SJ, Terezhalmy GT. The patient with an odontogenic infection. Quintessence Int 2004; 35(6): 482-502.
26. Bratton TA, Jackson DC, Nkungula-Howlett T, Williams CW, Bennett CR. Management of complex multi-space odontogenic infections. J Tenn Dent Assoc 2002; 82(3): 39-47.
27. Ashkenazi M, Ashkenazi S. Judicious use of antibiotics in dental practice. Refuat Hapeh Vehashinayim 2004; 21(4): 27-34, 94. (Hebrew)
28. Litterio M, Bianchini H, Carloni G, Di Martino A, Fernández Canigia L, Greco G, et al. "In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002. Rev Argent Microbiol 2004; 36(3): 130-135 (Spanish)
29. Eckert AW, Höhne C, Schubert J. Pathogen spectrum and resistance status of exclusively anaerobic odontogenic infections. Mund Kiefer Gesichtschir 2000; 4(3): 153-158 (German)
30. Rotimi VO, Salako NO, Mokaddas E, Philip L, Rajan P. High frequency of isolation of antibiotic-resistant oral Viridans streptococci from children in Kuwait. J Chemother 2005; 17(5): 493-501. (Pubitemid 41695596)
31. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996; 40(4): 891-894
32. Traub WH, Leonhard B. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 1997; 43(1): 10-20.
33. Traub WH, Leonhard B. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs. Chemotherapy 1997; 43(2): 123-131 (Pubitemid 27099903)
34. Rozkiewicz D, Daniluk T, Sciepuk M, Zaremba ML, Cylwik-Rokicka D, Luczaj-Cepowicz E, et al. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population. Adv Med Sci 2006; 51 Suppl 1: 191-195
35. Limeres J, Tomás I, Alvarez M, Diz P. Empirical antimicrobial therapy for odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100(3): 263-264 (Pubitemid 41191334)
36. Moenning JE, Nelson CL, Kohler RB. The microbiology and chemotherapy of odontogenic infections. J Oral Maxillofac Surg 1989; 47(9): 976-985
37. Matijević S, Lazić Z, Nonković Z. Clinical efficacy of ampicillin to treatments of acute odontogenic abcsesses. Vojnosanit Pregl 2009; 66(2): 123-128